Nasdaq:US$16.55 (-0.13) | HKEX:HK$26.55 (-0.10) | AIM:£2.70 (+0.02)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 其他業務 | 2014-04-17

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture